175 related articles for article (PubMed ID: 1719234)
1. Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses.
Dillner L; Heino P; Moreno-Lopez J; Dillner J
J Virol; 1991 Dec; 65(12):6862-71. PubMed ID: 1719234
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
[TBL] [Abstract][Full Text] [Related]
3. Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope.
Jenison SA; Yu XP; Valentine JM; Galloway DA
J Virol; 1989 Feb; 63(2):809-18. PubMed ID: 2463384
[TBL] [Abstract][Full Text] [Related]
4. Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region.
Strike DG; Bonnez W; Rose RC; Reichman RC
J Gen Virol; 1989 Mar; 70 ( Pt 3)():543-55. PubMed ID: 2471790
[TBL] [Abstract][Full Text] [Related]
5. Mapping of linear B cell epitopes on capsid proteins of bovine papillomavirus: identification of three external type-restricted epitopes.
Cason J; Kambo PK; Jewers RJ; Chrystie IL; Best JM
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2669-77. PubMed ID: 8277272
[TBL] [Abstract][Full Text] [Related]
6. Purification of papillomavirus structural polypeptides from papillomas by immunoaffinity chromatography.
Nakai Y; Lancaster WD; Jenson AB
J Gen Virol; 1987 Jul; 68 ( Pt 7)():1891-6. PubMed ID: 3037012
[TBL] [Abstract][Full Text] [Related]
7. Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins.
Beiss BK; Heimer E; Felix A; Burk RD; Ritter DB; Mallon RG; Kadish AS
Virology; 1991 Sep; 184(1):460-4. PubMed ID: 1714667
[TBL] [Abstract][Full Text] [Related]
8. Antibody-mediated neutralization in vivo of infectious papillomaviruses.
Christensen ND; Kreider JW
J Virol; 1990 Jul; 64(7):3151-6. PubMed ID: 1693698
[TBL] [Abstract][Full Text] [Related]
9. Topographical and conformational epitopes of bovine papillomavirus type 1 defined by monoclonal antibodies.
Cowsert LM; Lake P; Jenson AB
J Natl Cancer Inst; 1987 Nov; 79(5):1053-7. PubMed ID: 2446044
[TBL] [Abstract][Full Text] [Related]
10. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
11. Bovine papillomavirus type 1 monoclonal antibodies.
Gorra JB; Lancaster WD; Kurman RJ; Jenson AB
J Natl Cancer Inst; 1985 Jul; 75(1):121-5. PubMed ID: 2989600
[TBL] [Abstract][Full Text] [Related]
12. A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles.
Eklund C; Dillner J
J Virol Methods; 1995 May; 53(1):11-23. PubMed ID: 7635919
[TBL] [Abstract][Full Text] [Related]
13. Identification of linear epitopes of the BPV-1 L1 protein recognized by sera of infected or immunized animals.
Jenson AB; Lim P; Ghim S; Cowsert L; Olson C; Lim LY; Farquhar C; Pilacinski W
Pathobiology; 1991; 59(6):396-403. PubMed ID: 1718315
[TBL] [Abstract][Full Text] [Related]
14. Identification of the bovine papillomavirus L1 gene product using monoclonal antibodies.
Cowsert LM; Pilacinski WP; Jenson AB
Virology; 1988 Aug; 165(2):613-5. PubMed ID: 2841806
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity of bovine papillomavirus type 1 (BPV-1) L1 virus-like particles compared with that of intact BPV-1 virions.
Ghim SJ; Young R; Jenson AB
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():183-8. PubMed ID: 8627221
[TBL] [Abstract][Full Text] [Related]
16. Identification of conformational epitopes of the BPV-1 capsid recognized by competitive inhibition of sera from infected or immunized animals.
Ghim SJ; Jenson AB
Pathobiology; 1993; 61(3-4):138-44. PubMed ID: 8216835
[TBL] [Abstract][Full Text] [Related]
17. Targeting synthetic Human Papillomavirus (HPV) L2 disulfide-induced N-terminus conformational epitopes for pan-HPV vaccine development.
Khanal S; Ferraris ED; Zahin M; Joh J; Ghim SJ; Jenson AB
Exp Mol Pathol; 2015 Oct; 99(2):330-4. PubMed ID: 26134615
[TBL] [Abstract][Full Text] [Related]
18. Identification of L2 open reading frame gene products of bovine papillomavirus type 1 using monoclonal antibodies.
Jin XW; Cowsert LM; Pilacinski WP; Jenson AB
J Gen Virol; 1989 May; 70 ( Pt 5)():1133-40. PubMed ID: 2471804
[TBL] [Abstract][Full Text] [Related]
19. Induction of neutralizing antibodies to papillomaviruses by anti-idiotypic antibodies.
Christensen ND; Reed CA; Cladel NM
Virology; 1995 Jul; 210(2):292-301. PubMed ID: 7542415
[TBL] [Abstract][Full Text] [Related]
20. Demonstration of evolutionary differences between conserved antigenic epitopes in the minor nucleocapsid protein of human papillomavirus types 6b, 16 and 18.
Lehtinen M; Parkkonen P; Niemelä J; Paavonen J
Biochem Biophys Res Commun; 1990 Nov; 172(3):1378-83. PubMed ID: 1700908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
